Engineering hyaluronic acid-based cryogels for CD44-mediated breast tumor reconstruction.

Breast cancer CD44 Cryogels Hyaluronic acid Tumor models

Journal

Materials today. Bio
ISSN: 2590-0064
Titre abrégé: Mater Today Bio
Pays: England
ID NLM: 101757228

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 07 11 2021
revised: 19 01 2022
accepted: 22 01 2022
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 25 2 2022
Statut: epublish

Résumé

Breast cancer is a major health concern worldwide and is the leading cause of cancer-related death among American women. Traditional therapies, such as surgery, chemotherapy, and radiotherapy, are usually ineffective. Furthermore, cancer recurrence following targeted therapy often results from acquired drug resistance. Therefore, more realistic tumor models than monolayer cell culture for drug screening and discovery in an

Identifiants

pubmed: 35198956
doi: 10.1016/j.mtbio.2022.100207
pii: S2590-0064(22)00005-9
pmc: PMC8844817
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100207

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB027705
Pays : United States

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Front Bioeng Biotechnol. 2021 Feb 05;9:611837
pubmed: 33614611
Cancers (Basel). 2021 Jun 23;13(13):
pubmed: 34201840
J Biomater Appl. 2017 May;31(10):1380-1390
pubmed: 28376672
Exp Cell Res. 2004 Oct 15;300(1):180-9
pubmed: 15383325
Dent Mater. 2018 Jan;34(1):120-131
pubmed: 29199009
Cell. 2006 Nov 17;127(4):679-95
pubmed: 17110329
Adv Healthc Mater. 2014 Apr;3(4):500-7
pubmed: 24030924
Int J Cancer. 1997 Nov 4;73(3):327-31
pubmed: 9359477
PLoS One. 2017 Apr 21;12(4):e0175960
pubmed: 28430808
FASEB J. 1992 Apr;6(7):2397-404
pubmed: 1563592
Biomed Microdevices. 2006 Jun;8(2):109-18
pubmed: 16688570
Adv Sci (Weinh). 2021 Jul 20;8(18):2100316
pubmed: 34580619
J Microsc. 2013 Sep;251(3):250-60
pubmed: 23924043
Sci Rep. 2020 Oct 27;10(1):18370
pubmed: 33110210
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Biomaterials. 2008 Apr;29(12):1739-49
pubmed: 18234331
Int J Breast Cancer. 2012;2012:574025
pubmed: 22482059
Nanomaterials (Basel). 2017 Dec 10;7(12):
pubmed: 29232876
Semin Cancer Biol. 2015 Dec;35:3-10
pubmed: 26416466
PLoS One. 2015 Apr 09;10(4):e0123312
pubmed: 25856378
Biomaterials. 2016 Mar;81:135-156
pubmed: 26731577
J Cancer. 2017 Feb 25;8(5):761-773
pubmed: 28382138
Oncogene. 2007 Feb 26;26(9):1324-37
pubmed: 17322918
Sci Rep. 2014 Apr 16;4:4706
pubmed: 24736500
Front Immunol. 2020 Jul 08;11:1171
pubmed: 32733438
Cancer Res. 2010 Nov 15;70(22):9298-308
pubmed: 20870744
J Hematol Oncol. 2018 May 10;11(1):64
pubmed: 29747682
FEBS Lett. 2007 Sep 18;581(23):4523-8
pubmed: 17765896
Sci Rep. 2018 Feb 5;8(1):2365
pubmed: 29403007
Cancer Cell. 2007 Mar;11(3):259-73
pubmed: 17349583
Cell Adh Migr. 2012 May-Jun;6(3):249-60
pubmed: 22568982
J Exp Med. 1979 Feb 1;149(2):507-15
pubmed: 762499
Tissue Eng Part B Rev. 2010 Jun;16(3):351-9
pubmed: 20092396
J Biomed Mater Res A. 2009 Jul;90(1):142-53
pubmed: 18491397
Biotechnol Lett. 2016 Aug;38(8):1389-95
pubmed: 27167883
J Biomol Screen. 2011 Feb;16(2):141-54
pubmed: 21297102
Cell Rep. 2017 Aug 15;20(7):1641-1653
pubmed: 28813675
Adv Funct Mater. 2021 Sep 9;31(37):
pubmed: 37745940
Biomaterials. 2011 Jun;32(18):4205-10
pubmed: 21515168
Cancer Cell. 2020 Apr 13;37(4):496-513
pubmed: 32289273
J Cell Physiol. 2018 Apr;233(4):2993-3003
pubmed: 28618001
Materials (Basel). 2018 Aug 07;11(8):
pubmed: 30087295
Macromol Rapid Commun. 2014 Sep;35(18):1578-86
pubmed: 25113941
Nat Commun. 2015 Aug 12;6:7556
pubmed: 26265369
BMC Biol. 2012 Mar 22;10:29
pubmed: 22439642
Int J Biol Macromol. 2016 Dec;93(Pt B):1410-1419
pubmed: 27185069
J R Soc Interface. 2017 Feb;14(127):
pubmed: 28202590
Front Bioeng Biotechnol. 2018 May 24;6:66
pubmed: 29881724
Int J Nanomedicine. 2017 Oct 31;12:7993-8007
pubmed: 29184400
Biomaterials. 2013 Dec;34(38):10143-50
pubmed: 24075410
Bioelectricity. 2020 Sep 1;2(3):279-292
pubmed: 34476358
Breast Cancer Res Treat. 2014 Jan;143(2):277-86
pubmed: 24337597
Materials (Basel). 2019 Sep 11;12(18):
pubmed: 31514390
Front Immunol. 2015 May 06;6:201
pubmed: 25999946
Trends Biotechnol. 2013 Feb;31(2):108-15
pubmed: 23336996
Cells. 2018 Dec 19;7(12):
pubmed: 30572633
Sci Rep. 2018 Nov 21;8(1):17145
pubmed: 30464248
Front Immunol. 2015 Apr 08;6:154
pubmed: 25904917
Sci Adv. 2018 Apr 27;4(4):eaas8998
pubmed: 29719868
Front Oncol. 2015 Oct 20;5:224
pubmed: 26539408
PLoS One. 2019 Jan 24;14(1):e0211078
pubmed: 30677075
J Biomed Sci. 2012 Dec 14;19:102
pubmed: 23241400
Front Immunol. 2019 May 10;10:947
pubmed: 31134064
Biotechnol J. 2017 Jan;12(1):
pubmed: 27966285
PLoS One. 2014 Mar 24;9(3):e92511
pubmed: 24663399
Acta Biomater. 2017 Oct 15;62:42-63
pubmed: 28736220
Biomater Sci. 2020 Aug 7;8(15):4073-4094
pubmed: 32539055
FEBS J. 2011 May;278(9):1429-43
pubmed: 21362138
Langmuir. 2013 Jun 18;29(24):7393-400
pubmed: 23343008
PLoS One. 2015 Jun 19;10(6):e0130348
pubmed: 26090664
J Vis Exp. 2019 Jan 18;(143):
pubmed: 30735201
Front Bioeng Biotechnol. 2016 Feb 12;4:12
pubmed: 26904541
J Periodontal Implant Sci. 2013 Dec;43(6):251-61
pubmed: 24455437
Tissue Eng Part A. 2021 Jun;27(11-12):748-760
pubmed: 33108972
J Immunol. 1984 Dec;133(6):3387-95
pubmed: 6238097
Nat Protoc. 2018 Sep;13(9):1917-1957
pubmed: 30190554
PLoS One. 2015 Sep 17;10(9):e0138137
pubmed: 26379032
Nat Rev Cancer. 2018 Aug;18(8):485-499
pubmed: 29703913
Expert Opin Biol Ther. 2012 Oct;12(10):1347-60
pubmed: 22784238
Cancer Metastasis Rev. 2013 Jun;32(1-2):303-15
pubmed: 23114846
Clin Cancer Res. 2018 Feb 15;24(4):727-729
pubmed: 29222163
Biochem Soc Trans. 2020 Apr 29;48(2):657-665
pubmed: 32311020
Signal Transduct Target Ther. 2021 Jan 12;6(1):12
pubmed: 33436555
Sci Rep. 2017 Feb 16;7:42855
pubmed: 28205621
Adv Healthc Mater. 2019 Sep;8(17):e1900679
pubmed: 31348620
Cancer Cell Int. 2021 Mar 4;21(1):152
pubmed: 33663530
Front Immunol. 2020 May 15;11:940
pubmed: 32499786

Auteurs

Mahboobeh Rezaeeyazdi (M)

Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA.

Thibault Colombani (T)

Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA.

Loek J Eggermont (LJ)

Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA.

Sidi A Bencherif (SA)

Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA.
Department of Bioengineering, Northeastern University, Boston, MA, 02115, USA.
Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA.

Classifications MeSH